Frankfurt - Delayed Quote • EUR
Bioextrax AB (publ) (85X0.F)
As of 3:29 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,278.0000
395.0000
276.0000
21.7760
Cost of Revenue
1,474.0000
1,345.0000
1,033.0000
757.0020
Gross Profit
-196.0000
-950.0000
-757.0000
-735.2260
Operating Expense
20,876.0000
17,717.0000
9,772.0000
4,833.5710
Operating Income
-21,072.0000
-18,667.0000
-10,529.0000
-5,568.7970
Net Non Operating Interest Income Expense
12.0000
--
-3.0000
-2.8430
Pretax Income
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Net Income Common Stockholders
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Diluted NI Available to Com Stockholders
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Basic EPS
-0.85
-1.10
-0.79
-0.46
Diluted EPS
-0.85
-1.10
-0.79
-0.46
Basic Average Shares
24,811.6910
16,898.8580
13,403.2720
13,107.5500
Diluted Average Shares
29,233.8550
16,898.8580
13,403.2720
15,594.7800
Total Operating Income as Reported
-21,072.0000
-18,667.0000
-10,529.0000
-5,568.7970
Total Expenses
22,350.0000
19,062.0000
10,805.0000
5,590.5730
Net Income from Continuing & Discontinued Operation
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Normalized Income
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Interest Income
11.0000
--
--
--
Interest Expense
-1.0000
--
3.0000
2.8430
Net Interest Income
12.0000
--
-3.0000
-2.8430
EBIT
-21,061.0000
-18,667.0000
-10,529.0000
-5,568.7970
EBITDA
-20,377.0000
-18,190.0000
-10,179.0000
-5,396.4050
Reconciled Cost of Revenue
1,474.0000
1,345.0000
1,033.0000
757.0020
Reconciled Depreciation
684.0000
477.0000
350.0000
172.3920
Net Income from Continuing Operation Net Minority Interest
-21,060.0000
-18,667.0000
-10,532.0000
-5,571.6400
Normalized EBITDA
-20,377.0000
-18,190.0000
-10,179.0000
-5,396.4050
12/31/2020 - 5/10/2021
Yahoo Finance Plus Essential access required. Unlock Access